The DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.
Polymer–drug conjugates: Origins, progress to date and future directions
Open accessAbstract
This overview focuses on bioconjugates of water-soluble polymers with low molecular weight drugs and proteins. After a short discussion of the origins of the field, the state-of-the-art is reviewed. Then research directions needed for the acceleration of the translation of nanomedicines into the clinic are outlined. Two most important directions, synthesis of backbone degradable polymer carriers and drug-free macromolecular therapeutics, a new paradigm in drug delivery, are discussed in detail. Finally, the future perspectives of the field are briefly discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200902672 · Cited by 3,533
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
McLaughlin, P., Grillo-López, A. J., Link, B. K., Levy, R., Czuczman, M. S., Williams, M. E., Heyman, M. R., Bence-Bruckler, I., White, C. A., Cabanillas, F., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2825 · Cited by 2,755
Imaging in the era of molecular oncology
Weissleder, R., & Pittet, M. J. (2008) · Nature · doi:10.1038/nature06917 · Cited by 2,364
Provenzano, P. P., Cuevas, C., Chang, A. E., Goel, V. K., Von Hoff, D. D., & Hingorani, S. R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.01.007 · Cited by 2,195
Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20
Reff, M., Carner, K., Chambers, K., Chinn, P., Leonard, J., Raab, R., Newman, R., Hanna, N., & Anderson, D. (1994) · Blood · doi:10.1182/blood.v83.2.435.435 · Cited by 1,999
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
Aller, S. G., Yu, J., Ward, A., Weng, Y., Chittaboina, S., Zhuo, R., Harrell, P. M., Trinh, Y. T., Zhang, Q., Urbatsch, I. L., et al. (2009) · Science · doi:10.1126/science.1168750 · Cited by 1,929
The cancer stem cell: premises, promises and challenges
Clevers, H. (2011) · Nature Medicine · doi:10.1038/nm.2304 · Cited by 1,923
De Duve, C., De Barsy, T., Poole, B., Trouet, A., Tulkens, P., & Van Hoof, F. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90174-9 · Cited by 1,901
Abuchowski, A., McCoy, J. R., Palczuk, N. C., van Es, T., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40292-4 · Cited by 1,274
Imaging and drug delivery using theranostic nanoparticles
Janib, S. M., Moses, A. S., & MacKay, J. A. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.08.004 · Cited by 1,248
Molecular imaging in drug development
Willmann, J. K., van Bruggen, N., Dinkelborg, L. M., & Gambhir, S. S. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2290 · Cited by 1,171
Structure and properties of pharmacologically active polymers
Ringsdorf, H. (1975) · Journal of Polymer Science: Polymer Symposia · doi:10.1002/polc.5070510111 · Cited by 1,094
Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects
Maeda, H. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100070g · Cited by 998
Nanomedicine(s) under the Microscope
Duncan, R., & Gaspar, R. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200394t · Cited by 981
Hedgehog signalling in prostate regeneration, neoplasia and metastasis
Karhadkar, S. S., Steven Bova, G., Abdallah, N., Dhara, S., Gardner, D., Maitra, A., Isaacs, J. T., Berman, D. M., & Beachy, P. A. (2004) · Nature · doi:10.1038/nature02962 · Cited by 950
Lammers, T., Aime, S., Hennink, W. E., Storm, G., & Kiessling, F. (2011) · Accounts of Chemical Research · doi:10.1021/ar200019c · Cited by 870
Glutathione-Associated Enzymes In Anticancer Drug Resistance
Tew, K. D. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3143 · Cited by 856
Hedgehog signalling in cancer formation and maintenance
di Magliano, M. P., & Hebrok, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1229 · Cited by 829
Soluble Polymer Carriers for the Treatment of Cancer: The Importance of Molecular Architecture
Fox, M. E., Szoka, F. C., & Fréchet, J. M. J. (2009) · Accounts of Chemical Research · doi:10.1021/ar900035f · Cited by 748
Synthetic genetic polymers capable of heredity and evolution
Pinheiro, V. B., Taylor, A. I., Cozens, C., Abramov, M., Renders, M., Zhang, S., Chaput, J. C., Wengel, J., Peak-Chew, S.-Y., McLaughlin, S. H., et al. (2012) · Science · doi:10.1126/science.1217622 · Cited by 730
State of the art in PEGylation: The great versatility achieved after forty years of research
Pasut, G., & Veronese, F. M. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.037 · Cited by 720
Anderson, K., Bates, M., Slaughenhoupt, B., Pinkus, G., Schlossman, S., & Nadler, L. (1984) · Blood · doi:10.1182/blood.v63.6.1424.1424 · Cited by 704
Armstrong, J. K., Hempel, G., Koling, S., Chan, L. S., Fisher, T., Meiselman, H. J., & Garratty, G. (2007) · Cancer · doi:10.1002/cncr.22739 · Cited by 699
Vasey, P. A., Kaye, S. B., Morrison, R. A., Twelves, C. J., Wilson, P., Duncan, R., Thomson, A. H., Murray, L. S., Hilditch, T. E., Murray, T., et al. (1999) · PubMed · Cited by 689
Safra, T., Muggia, F., Jeffers, S., Tsao-Wei, D. D., Groshen, S., Lyass, O., Henderson, R., Berry, G., & Gabizon, A. (2000) · Annals of Oncology · doi:10.1023/a:1008365716693 · Cited by 618
CD20: a regulator of cell-cycle progression of B lymphocytes
Tedder, T. F., & Engel, P. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90276-3 · Cited by 590
HPMA copolymers: Origins, early developments, present, and future☆
Kopeček, J., & Kopečková, P. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.10.004 · Cited by 576
Self-citationIshida, T., Ichihara, M., Wang, X., Yamamoto, K., Kimura, J., Majima, E., & Kiwada, H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.01.005 · Cited by 557
Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes
Ishida, T., & Kiwada, H. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.11.005 · Cited by 490
Noguchi, Y., Wu, J., Duncan, R., Strohalm, J., Ulbrich, K., Akaike, T., & Maeda, H. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb00563.x · Cited by 470
Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma
Cheson, B. D., & Leonard, J. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0708875 · Cited by 438
Polymer-drug conjugates: Recent development in clinical oncology
Li, C., & Wallace, S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.009 · Cited by 436
Seymour, L. W., Duncan, R., Strohalm, J., & Kopeček, J. (1987) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820211106 · Cited by 436
Self-citationHepatic Drug Targeting: Phase I Evaluation of Polymer-Bound Doxorubicin
Seymour, L. W., Ferry, D. R., Anderson, D., Hesslewood, S., Julyan, P. J., Poyner, R., Doran, J., Young, A., Burtles, S. S., & Kerr, D. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1668 · Cited by 435
Polyoxazoline: Chemistry, Properties, and Applications in Drug Delivery
Viegas, T. X., Bentley, M. D., Harris, J. M., Fang, Z., Yoon, K., Dizman, B., Weimer, R., Mero, A., Pasut, G., & Veronese, F. M. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200049d · Cited by 432
Wang, Y.-S., Youngster, S., Grace, M., Bausch, J., Bordens, R., & Wyss, D. F. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00027-3 · Cited by 420
Peracchia, M. T., Fattal, E., Desmaële, D., Besnard, M., Noël, J. P., Gomis, J. M., Appel, M., d’Angelo, J., & Couvreur, P. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00063-2 · Cited by 400
Chen, H., Kim, S., Li, L., Wang, S., Park, K., & Cheng, J.-X. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707046105 · Cited by 394
Persidis, A. (1999) · Nature Biotechnology · doi:10.1038/5289 · Cited by 372
Biology of the multidrug resistance-associated protein, MRP
Loe, D. W., Deeley, R. G., & Cole, S. P. C. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00046-9 · Cited by 367
Ishida, T., Harada, M., Wang, X. Y., Ichihara, M., Irimura, K., & Kiwada, H. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.04.003 · Cited by 365
PEGylated Proteins: Evaluation of Their Safety in the Absence of Definitive Metabolism Studies
Webster, R., Didier, E., Harris, P., Siegel, N., Stadler, J., Tilbury, L., & Smith, D. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.012419 · Cited by 337
Pegaspargase: a review of clinical studies
Graham, M. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00110-8 · Cited by 322
Administration, distribution, metabolism and elimination of polymer therapeutics
Markovsky, E., Baabur-Cohen, H., Eldar-Boock, A., Omer, L., Tiram, G., Ferber, S., Ofek, P., Polyak, D., Scomparin, A., & Satchi-Fainaro, R. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.021 · Cited by 313
Smart Self‐Assembled Hybrid Hydrogel Biomaterials
Kopeček, J., & Yang, J. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201201040 · Cited by 313
Self-citationMono-N-terminal poly(ethylene glycol)–protein conjugates
Kinstler, O., Molineux, G., Treuheit, M., Ladd, D., & Gegg, C. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00023-6 · Cited by 306
Seymour (2009) · International Journal of Oncology · doi:10.3892/ijo_00000293 · Cited by 304
Intracellular targeting of polymer-bound drugs for cancer chemotherapy
NORI, A., & KOPECEK, J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.10.006 · Cited by 303
Poly[N-(2-hydroxypropyl)methacrylamide]—I. Radical polymerization and copolymerization
Kopeček, J., & Baẑilová, H. (1973) · European Polymer Journal · doi:10.1016/0014-3057(73)90063-3 · Cited by 300
Self-citationPEG-uricase in the management of treatment-resistant gout and hyperuricemia
Sherman, M. R., Saifer, M. G. P., & Perez-Ruiz, F. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.011 · Cited by 291
Oupicky, D., Ogris, M., Howard, K. A., Dash, P. R., Ulbrich, K., & Seymour, L. W. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0568 · Cited by 284
Meerum Terwogt, J. M., ten Bokkel Huinink, W. W., Schellens, J. H., Schot, M., Mandjes, I. A., Zurlo, M. G., Rocchetti, M., Rosing, H., Koopman, F. J., & Beijnen, J. H. (2001) · Anti-Cancer Drugs · doi:10.1097/00001813-200104000-00003 · Cited by 279
Bendele, A. M., Seely, J., Richey, C., Sennello, G., & Shopp, G. M. (1998) · Toxicological Sciences · doi:10.1006/toxs.1997.2396 · Cited by 279
Rejmanová, P., Kopeček, J., Pohl, J., Baudyš, M., & Kostka, V. (1983) · Die Makromolekulare Chemie · doi:10.1002/macp.1983.021841006 · Cited by 264
Self-citationPolymer therapeutics as nanomedicines: new perspectives
Duncan, R. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.05.507 · Cited by 254
PEGylated Protein Drugs: Basic Science and Clinical Applications
(2009) · doi:10.1007/978-3-7643-8679-5 · Cited by 241
Use of peginterferon alfa-2a (40 KD) (Pegasys®) for the treatment of hepatitis C
Rajender Reddy, K., Modi, M. W., & Pedder, S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00028-5 · Cited by 241
Development of macromolecular prodrug for rheumatoid arthritis
Yuan, F., Quan, L.-D., Cui, L., Goldring, S. R., & Wang, D. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.03.006 · Cited by 239
Sundy, J. S., Ganson, N. J., Kelly, S. J., Scarlett, E. L., Rehrig, C. D., Huang, W., & Hershfield, M. S. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22403 · Cited by 221
Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate
Omelyanenko, V, Kopečková, P., Gentry, C., & Kopeček, J. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00235-6 · Cited by 216
Self-citationLevy, Y., Hershfield, M. S., Fernandez-Mejia, C., Polmar, S. H., Scudiery, D., Berger, M., & Sorensen, R. U. (1988) · The Journal of Pediatrics · doi:10.1016/s0022-3476(88)80271-3 · Cited by 215
Rademaker-Lakhai, J. M., Terret, C., Howell, S. B., Baud, C. M., de Boer, R. F., Pluim, D., Beijnen, J. H., Schellens, J. H. M., & Droz, J.-P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0315 · Cited by 214
Looking ahead in cancer stem cell research
Dick, J. E. (2009) · Nature Biotechnology · doi:10.1038/nbt0109-44 · Cited by 211
Polymer Therapeutics Designed for a Combination Therapy of Hormone‐Dependent Cancer
Vicent, M. J., Greco, F., Nicholson, R. I., Paul, A., Griffiths, P. C., & Duncan, R. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200462960 · Cited by 199
Minko, T., Kope?kov�, P., & Kope?ek, J. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000401)86:1<108::aid-ijc17>3.0.co;2-8 · Cited by 198
Self-citationDuncan, R., Cable, H. C., Lloyd, J. B., Rejmanová, P., & Kopeček, J. (1983) · Die Makromolekulare Chemie · doi:10.1002/macp.1983.021841005 · Cited by 193
Self-citationGhetie, M.-A., Bright, H., & Vitetta, E. S. (2001) · Blood · doi:10.1182/blood.v97.5.1392 · Cited by 191
Structural and chemical aspects of HPMA copolymers as drug carriers☆
Ulbrich, K., & Šubr, V. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.10.007 · Cited by 186
Paz-Ares, L., Ross, H., O'Brien, M., Riviere, A., Gatzemeier, U., Von Pawel, J., Kaukel, E., Freitag, L., Digel, W., Bischoff, H., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604372 · Cited by 171
Schluep, T., Hwang, J., Hildebrandt, I. J., Czernin, J., Choi, C. H. J., Alabi, C. A., Mack, B. C., & Davis, M. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905487106 · Cited by 169
Targeting polymer therapeutics to bone
Low, S. A., & Kopec̆ek, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.01.012 · Cited by 161
Batrakova, E. V., Li, S., Brynskikh, A. M., Sharma, A. K., Li, Y., Boska, M. D., Gong, N., Mosley, R. L., Alakhov, V. Y., Gendelman, H. E., et al. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.004 · Cited by 159
Jatzkewitz, H. (1955) · Zeitschrift für Naturforschung B · doi:10.1515/znb-1955-0106 · Cited by 158
Synthesis and Evaluation of Water-Soluble Polymeric Bone-Targeted Drug Delivery Systems
Wang, D., Miller, S. C., Sima, M., Kopečková, P., & Kopec̆ek, J. (2003) · Bioconjugate Chemistry · doi:10.1021/bc034090j · Cited by 156
Ishihara, T., Maeda, T., Sakamoto, H., Takasaki, N., Shigyo, M., Ishida, T., Kiwada, H., Mizushima, Y., & Mizushima, T. (2010) · Biomacromolecules · doi:10.1021/bm100754e · Cited by 156
Controlled biodegradability of polymers — a key to drug delivery systems
Kopec̆ek, J. (1984) · Biomaterials · doi:10.1016/0142-9612(84)90062-0 · Cited by 155
Polymer–drug conjugates as nano-sized medicines
Canal, F., Sanchis, J., & Vicent, M. J. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.06.003 · Cited by 153
Yang, J., Xu, C., Wang, C., & Kopec̆ek, J. (2006) · Biomacromolecules · doi:10.1021/bm051002k · Cited by 149
Pakunlu, R. I., Wang, Y., Tsao, W., Pozharov, V. P., Cook, T. J., & Minko, T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0001 · Cited by 148
Koide, H., Asai, T., Hatanaka, K., Akai, S., Ishii, T., Kenjo, E., Ishida, T., Kiwada, H., Tsukada, H., & Oku, N. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.03.022 · Cited by 143
Shiah, J.-G., Dvořák, M., Kopečková, P., Sun, Y., Peterson, C. M., & Kopec̆ek, J. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00374-9 · Cited by 140
Luo, K., Yang, J., Kopečková, P., & Kopec̆ek, J. (2011) · Macromolecules · doi:10.1021/ma102574e · Cited by 140
Etrych, T., Šubr, V., Strohalm, J., Šírová, M., Řı́hová, B., & Ulbrich, K. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.06.029 · Cited by 136
Duncan, R., Kopec̆ek, J., Rejmanová, P., & Lloyd, J. B. (1983) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(83)90258-1 · Cited by 127
A phase I and pharmacokinetic study of MAG-CPT, a water-soluble polymer conjugate of camptothecin
Schoemaker, N. E., van Kesteren, C., Rosing, H., Jansen, S., Swart, M., Lieverst, J. A., Fraier, D., Breda, M., Pellizzoni, C., Spinelli, R., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600516 · Cited by 122
Minko, T., Kopečková, P., & Kopeček, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018959029186 · Cited by 121
Self-citationWu, K., Liu, J., Johnson, R. N., Yang, J., & Kopec̆ek, J. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200906232 · Cited by 120
Liu, X. M., Quan, L., Tian, J., Alnouti, Y., Fu, K., Thiele, G. M., & Wang, D. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9683-3 · Cited by 118
Targeting Angiogenesis-Dependent Calcified Neoplasms Using Combined Polymer Therapeutics
Segal, E., Pan, H., Ofek, P., Udagawa, T., Kopečková, P., Kopec̆ek, J., & Satchi‐Fainaro, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005233 · Cited by 116
Yang, J., Luo, K., Pan, H., Kopečková, P., & Kopec̆ek, J. (2010) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2010.10.005 · Cited by 114
Zhang, R., Luo, K., Yang, J., Sima, M., Sun, Y., Janat-Amsbury, M. M., & Kopec̆ek, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.12.009 · Cited by 110
Sprincl, L., Exner, J., Stĕrba, O., & Kopeček, J. (1976) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820100612 · Cited by 107
Self-citationPeterson, C. M., Lu, J., Sun, Y., Peterson, C. A., Shiah, J.-G., Straight, R. C., & Kopec̆ek, J. (1996) · PubMed · Cited by 106
Krinick, N. L., Sun, Y., Joyner, D. A., Spikes, J. D., Straight, R. C., & Kopeček, J. (1994) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856294x00040 · Cited by 106
Self-citationShiah, J.-G., Sun, Y., Kopečková, P., Peterson, C. M., Straight, R. C., & Kopec̆ek, J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00325-x · Cited by 105
Pan, H., Yang, J., Kopečková, P., & Kopec̆ek, J. (2010) · Biomacromolecules · doi:10.1021/bm101254e · Cited by 100
Minko, T., Kopečková, P., & Kopec̆ek, J. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00186-2 · Cited by 97
Wang, D., Sima, M., Mosley, R. L., Davda, J. P., Tietze, N., Miller, S. C., Gwilt, P. R., Kopečková, P., & Kopec̆ek, J. (2006) · Molecular Pharmaceutics · doi:10.1021/mp0600539 · Cited by 94
Segal, E., Pan, H., Benayoun, L., Kopečková, P., Shaked, Y., Kopeček, J., & Satchi‐Fainaro, R. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.059 · Cited by 92
Self-citationImmunogenicity and immunomodulatory properties of HPMA-based polymers☆
Říhová, B., & Kovář, M. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.10.005 · Cited by 90
Clinical status and optimal use of rituximab for B-cell lymphomas.
McLaughlin, P. J., White, C. A., Grillo-López, A. J., & Maloney, D. G. (1998) · PubMed · Cited by 84
Wang, X., Ishida, T., Ichihara, M., & Kiwada, H. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.01.008 · Cited by 83
Thomson, A. H., Vasey, P. A., Murray, L. S., Cassidy, J., Fraier, D., Frigerio, E., & Twelves, C. J. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690657 · Cited by 81
Design and development of polymer conjugates as anti-angiogenic agents
Segal, E., & Satchi‐Fainaro, R. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.06.005 · Cited by 78
Coiled-coil based drug-free macromolecular therapeutics: In vivo efficacy
Wu, K., Yang, J., Liu, J., & Kopec̆ek, J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.002 · Cited by 77
Kaminskas, L. M., McLeod, V. M., Porter, C. J. H., & Boyd, B. J. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22682 · Cited by 76
High-molecular weight HPMA copolymer–adriamycin conjugates
Dvořák, M., Kopečková, P., & Kopeček, J. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00087-5 · Cited by 75
Self-citationShiah, J.-G., Sun, Y., Peterson, C. M., & Kopeček, J. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00113-3 · Cited by 73
Self-citationLong‐term experience with poly(glycol monomethacrylate) gel in plastic operations of the nose
Voldřrich, Z., Tománek, Z., Vacik, J., & Kopečcek, J. (1975) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820090612 · Cited by 72
Kopeček, J. (1977) · PubMed · Cited by 72
Self-citationZhang, N., Khawli, L. A., Hu, P., & Epstein, A. L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0554 · Cited by 71
Hongrapipat, J., Kopečková, P., Liu, J., Prakongpan, S., & Kopec̆ek, J. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800006e · Cited by 70
Targetable water-soluble polymer-drug conjugates for the treatment of visceral leishmaniasis
Nan, A., Croft, S. L., Yardley, V., & Ghandehari, H. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.09.012 · Cited by 70
Bypassing multidrug resistance in human breast cancer cells with lipid/polymer particle assemblies
Jin, Y., Li, Jin, Y., Xie, Yao, Li, & Qiu (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s27864 · Cited by 70
Biological tolerance of ionogenic hydrophilic gels
Sprincl, L., Vacik, J., & Kopec̆ek, J. (1973) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820070110 · Cited by 68
Clinical Implications of N-(2-Hydroxypropyl)Methacrylamide Copolymers
Rihova, B., & Kubáčková, K. (2003) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201033489711 · Cited by 68
Selective inhibitory effect of HPMA copolymer-cyclopamine conjugate on prostate cancer stem cells
Zhou, Y., Yang, J., & Kopec̆ek, J. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.029 · Cited by 68
Biological rationale for the design of polymeric anti-cancer nanomedicines
Zhou, Y., & Kopec̆ek, J. (2012) · Journal of drug targeting · doi:10.3109/1061186x.2012.723213 · Cited by 68
Biological tolerance of poly(N‐substituted methacrylamides)
Sprincl, L., Vacik, J., Kopec̆ek, J., & Lím, D. (1971) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820050307 · Cited by 66
Kopec̆ek, J., Sprincl, L., & Lím, D. (1973) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820070206 · Cited by 64
BIODEGRADATION OF POLYMERS FOR BIOMEDICAL USE
Kopec̆ek, J. (1982) · Elsevier eBooks · doi:10.1016/b978-0-08-026226-0.50026-9 · Cited by 63
Molecular imaging of HPMA copolymers: Visualizing drug delivery in cell, mouse and man☆
Lu, Z. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.12.007 · Cited by 63
Callahan, J., & Kopec̆ek, J. (2006) · Biomacromolecules · doi:10.1021/bm060336m · Cited by 63
Polymers containing enzymatically degradable bonds V. Hydrophilic polymers degradable by papain
Ulbrich, K., Zacharieva, E. I., Obereigner, B., & Kopec̆ek, J. (1980) · Biomaterials · doi:10.1016/0142-9612(80)90017-4 · Cited by 63
Pan, H., Sima, M., Yang, J., & Kopec̆ek, J. (2013) · Macromolecular Bioscience · doi:10.1002/mabi.201200353 · Cited by 62
The Arthrotropism of Macromolecules in Adjuvant-Induced Arthritis Rat Model: A Preliminary Study
Wang, D., Miller, S. C., Sima, M., Parker, D. L., Buswell, H. R., Goodrich, K. C., Kope#x010D;kov#x00E1;, P., & Kope#x010D;ek, J. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000045232.18134.e9 · Cited by 62
Anti-CD20 multivalent HPMA copolymer-Fab′ conjugates for the direct induction of apoptosis
Chu, T.-W., Yang, J., & Kopec̆ek, J. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.06.024 · Cited by 61
The Bone, the Joints and the Balm of Gilead
Wang, D., & Goldring, S. R. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200328t · Cited by 61
D’Souza, G. G. M., & Weissig, V. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903236101 · Cited by 60
Mimeault, M., Johansson, S. L., Hénichart, J., Depreux, P., & Batra, S. K. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1013 · Cited by 58
Novel HPMA Copolymer-Bound Constructs for Combined Tumor and Mitochondrial Targeting
Cuchelkar, V., Kopečková, P., & Kopec̆ek, J. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800019g · Cited by 57
Li, C., Cao, J., Wang, Y., Zhao, X., Deng, C., Wei, N., Yang, J., & Cui, J. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23254 · Cited by 57
Ma, Y., Yang, Q., Wang, L., Zhou, X., Zhao, Y., & Deng, Y. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.11.014 · Cited by 57
Polymers containing enzymatically degradable bonds, 4. Preliminary experiments in vivo
Kopec̆ek, J., Cífková, I., Rejmanová, P., Strohalm, J., Obereigner, B., & Ulbrich, K. (1981) · Die Makromolekulare Chemie · doi:10.1002/macp.1981.021821102 · Cited by 55
Water-soluble HPMA copolymer—prostaglandin E1conjugates containing a cathepsin K sensitive spacer
Pan, H., Kopečková, P., Wang, D., Yang, J., Miller, S. C., & Kopec̆ek, J. (2006) · Journal of drug targeting · doi:10.1080/10611860600834219 · Cited by 53
Šubr, V., Kopec̆ek, J., Pohl, J., Baudyš, M., & Kostka, V. (1988) · Journal of Controlled Release · doi:10.1016/0168-3659(88)90039-9 · Cited by 51
Dynamic Light Scattering Study of Self-Assembly of HPMA Hybrid Graft Copolymers
Yang, J., Wu, K., Koňák, Č., & Kopec̆ek, J. (2008) · Biomacromolecules · doi:10.1021/bm701001f · Cited by 50
Biological tolerance of poly(N‐substituted acrylamides)
Kopec̆ek, J., Sprincl, L., Baźilová, H., & Vacik, J. (1973) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820070109 · Cited by 50
Modulating antibody pharmacokinetics using hydrophilic polymers
Chen, C., Constantinou, A., & Deonarain, M. P. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.602399 · Cited by 49
Nishiyama, N., Nori, A., Malugin, A., Kasuya, Y., Kopečková, P., & Kopec̆ek, J. (2003) · PubMed · Cited by 49
Joyce, G. F. (2012) · Science · doi:10.1126/science.1221724 · Cited by 46
Biomaterials and Drug Delivery: Past, Present, and Future
Kopec̆ek, J. (2010) · Molecular Pharmaceutics · doi:10.1021/mp1001813 · Cited by 45
Kamei, S., & Kopeček, J. (1995) · Pharmaceutical Research · doi:10.1023/a:1016247206531 · Cited by 43
Self-citationControlled Release of Drug Model from N‐(2‐Hydroxypropyl)‐methacrylamide Copolymers
Kopec̆ek, J., Rejmanová, P., Duncan, R., & Lloyd, J. B. (1985) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1985.tb18393.x · Cited by 43
Beyond oncology — Application of HPMA copolymers in non-cancerous diseases☆
Liu, X.-M., Miller, S. C., & Wang, D. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.10.006 · Cited by 41
Cytotoxicity and immunostimulation: double attack on cancer cells with polymeric therapeutics
Říhová, B., Kovář, L., Kovář, M., & Hovorka, O. (2008) · Trends in biotechnology · doi:10.1016/j.tibtech.2008.10.006 · Cited by 40
Intracellular Trafficking and Subcellular Distribution of a Large Array of HPMA Copolymers
Callahan, J., Kopečková, P., & Kopec̆ek, J. (2009) · Biomacromolecules · doi:10.1021/bm801514x · Cited by 38
Kopec̆ek, J., & Rejmanová, P. (1979) · Journal of Polymer Science Polymer Symposia · doi:10.1002/polc.5070660105 · Cited by 34
Novel star HPMA-based polymer conjugates for passive targeting to solid tumors
Etrych, T., Strohalm, J., Chytil, P., Řı́hová, B., & Ulbrich, K. (2011) · Journal of drug targeting · doi:10.3109/1061186x.2011.622402 · Cited by 33
Self-association properties of HPMA copolymers containing an amphipathic heptapeptide
Ding, H., Kopečková, P., & Kopeček, J. (2007) · Journal of drug targeting · doi:10.1080/10611860701500016 · Cited by 29
Self-citationEnzymatically Degradable Bonds in Synthetic Polymers
Kopeček, J., & Rejmanová, P. (2019) · CRC Press eBooks · doi:10.1201/9780429262258-4 · Cited by 27
Self-citationPan, H., Liu, J., Dong, Y., Sima, M., Kopečková, P., Brandi, M. L., & Kopec̆ek, J. (2008) · Macromolecular Bioscience · doi:10.1002/mabi.200700338 · Cited by 26
Relationship between the structure and biocompatibility of hydrophilic gels.
Kopec̆ek, J., & Sprincl, L. (1974) · PubMed · Cited by 21
Design of Polymer‐Drug Conjugates
Kopec̆ek, J., & Kopečková, P. (2011) · Wiley eBooks · doi:10.1002/9783527634057.ch17 · Cited by 15
Riaz, W., Hernandez‐Ilizaliturri, F. J., & Czuczman, M. S. (2009) · Immunologic Research · doi:10.1007/s12026-009-8121-x · Cited by 12
Cited by
Ulbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,730
Controlled Drug Delivery Systems: Current Status and Future Directions
Adepu, S., & Ramakrishna, S. (2021) · Molecules · doi:10.3390/molecules26195905 · Cited by 1,691
Diverse Applications of Nanomedicine
Pelaz, B., Alexiou, C., Alvarez-Puebla, R. A., Alves, F., Andrews, A. M., Ashraf, S., Balogh, L. P., Ballerini, L., Bestetti, A., Brendel, C., et al. (2017) · ACS Nano · doi:10.1021/acsnano.6b06040 · Cited by 1,350
Self-citationThe Current State of Peptide Drug Discovery: Back to the Future?
Henninot, A., Collins, J. C., & Nuss, J. M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00318 · Cited by 1,113
Clinical Translation of Nanomedicine
Min, Y., Caster, J. M., Eblan, M. J., & Wang, A. Z. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00116 · Cited by 772
Metadata
- Authors
- Kopeček, J.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 65
- Issue
- 1
- Pages
- 49-59
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2151477149
- Cited by
- 347
- References
- 157
- FWCI
- 1.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.